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Objective. Current treatments for long-term depression – medication and psy-
chotherapy – are effective for some but not all clients. New approaches need to be
developed to complement the ones already available. This study was designed to test the
feasibility of using an effective post-traumatic stress disorder treatment for people with
long-term depression.
Design. A single-case experimental design with replications was undertaken as a
feasibility study of eye movement desensitization and reprocessing (EMDR) in treating
long-term depression.
Methods. Thirteen people with recurrent and/or long-term depression were recruited
from primary care mental health services and given standard protocol EMDR for a
maximumof 20 sessions. Levels of depression weremeasured before and after treatment
and at follow-up, clients also rated their mood each day.
Results. Eight people engagedwith the treatment; seven of these had clinically significant
and statistically reliable improvement on the Hamilton Rating Scale for Depression. Daily
mood ratings were highly variable both during baseline and intervention.
Conclusions. EMDR is a feasible treatment for recurrent and/or long-term depression.
Research on treatment efficacy and effectiveness is now required.
Practitioner points
 EMDR may be an effective treatment for depression.
 EMDR could be considered if first-line approaches (CBT and counselling) have been tried and failed.
 EMDR may be particularly helpful for service users with a history of trauma.
Long-term depression comprises of recurrent major depressive disorder (MDD; two or
more episodes) and persistent depressive disorder (a chronic episode of depression that
lasts for more than 2 years; APA, 2013). Although some consider recurrent and chronic
depression to be different illnesses (Klein & Santiago, 2003), identifying the correct
diagnosis in a particular client is hampered by incomplete remission and memory bias.
Current recommended treatments for depression include antidepressant medication,
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cognitive behavioural therapy (CBT), counselling, and interpersonal therapy (NCCMH,
2010). However, despite the efficacy of these interventions (Butler, Chapman, Forman, &
Beck, 2006; Olfson, Marcus, Tedeschi, & Wan, 2006), they do have limitations. In long-
term depression, typical response rates to both medication and psychotherapy may be
<50% (Torpey & Klein, 2008). Psychotherapy for long-term depression may be less
effective than for acute-phase depression (Cuijpers et al., 2010).
Eye movement desensitization and reprocessing (EMDR; Shapiro, 1995) is a
psychotherapy that was initially developed for the treatment of post-traumatic stress
disorder (PTSD). A Cochrane Collaboration review of treatments for chronic PTSD
recommended EMDR, trauma-focussed CBT (group and individual) and non-trauma-
focussed CBT (Bisson, Roberts, Andrew, Cooper, & Lewis, 2013). There is interest
amongst EMDR clinicians in using EMDR with other diagnoses. The theoretical model
behind EMDR, the adaptive information processing model (AIP), suggests that problem-
atic memories of trauma events are the cause of pathology and these are not limited to
PTSD (Solomon & Shapiro, 2008). Four randomized controlled trials into EMDR for PTSD
have also reported significant improvements in comorbid depression (Arabia, Manca, &
Solomon, 2011; Ironson et al., 2002; Lee, Gavriel, Drummond, Richards, & Greenwald,
2002; van der Kolk et al., 2007). However, there is little research into EMDR for clients
who have a primary diagnosis of depression without PTSD; this is limited to case studies
and clinical reports (Wood & Ricketts, 2013).
Life events describe any stressful occurrence in a person’s life, these can be positive
such asmoving house or gettingmarried, or negative such as getting ill or being assaulted.
In the EMDR literature, life events are sometimes referred to as ‘small t traumas’ (as
opposed to ‘big T traumas’ which are the life-threatening events associated with PTSD
onset). Depression is often associated with negative life events (Lenze, Cyranowski,
Thompson, Anderson, & Frank, 2008), and peoplewith chronic depression tend to report
greater levels of early life adversity (Riso & Newman, 2003). Childhood trauma is a direct
and strong risk factor for developing depression later in life (Heim, Newport, Mletzko,
Miller, & Nemeroff, 2008). There is a strong dose–response relationship between adverse
childhood experiences and lifetime depressive illness (Chapman et al., 2004), and it can
be considered a determinate for chronicity (Wiersma et al., 2009), earlier onset (Bernet &
Stein, 1999), more lifetime episodes (Bernet & Stein, 1999), and treatment resistance
(Kaplan & Klinetob, 2000). In theory, if EMDR is designed to treat the effect of being
traumatized and depression is associated with a high incidence of trauma, then EMDR
should be able to treat depression. Therefore, the aim of this research was to investigate
whether EMDRhas the potential to be a treatment for long-term depressionwithout PTSD
by testingwhether it is (1) feasible to deliver, (2) acceptable to patients, and (3) associated
with reductions in symptoms of depression.
Method
As there is little research on EMDR and depression (Wood & Ricketts, 2013), this study
followed the Medical Research Council guidelines (Craig et al., 2008) and began with a
feasibility study.
Design
A single-case experimental design (SCED) with replications (Barlow&Hersen, 1984) was
used. Before and after, measures were used to see whether change occurred, with the
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primary outcome being change on the Hamilton Rating Scale for Depression (HRSD;
Hamilton, 1960). A daily measure of low mood was also completed to investigate whether
change in mood was associated with delivery of EMDR. An AB design was used, with
baseline periods duringwhich the participant rated theirmood on the dailymeasure before
receiving treatment. The baselines were between 9 and 48 days long and were used to
predict natural fluctuations in mood. Once treatment started, the daily measure ratings
continued and were used to show how and when change occurred, if it occurred at all.
Participants
Thirteen patientswere recruitedwith a primary diagnosis of long-term depression (defined
as at least 2 years in duration or two or more episodes over the lifetime; APA, 2003).
Although they did not need to be native English speakers, they did need sufficient English to
be able to understand the testing and fully describe their memories. They had all received
treatment from the United Kingdom improving access to psychological therapy (IAPT)
primary care mental health service. Their therapist then introduced them to the research,
and if interested, their details were passed to the researcher. They were screened using the
Mini-international neuropsychiatric interview (MINI; Sheehan et al., 1998).
Inclusion criteria – People aged 18 and over, with long-term depression, confirmed
through structured interview (MINI) to ensure they met the DSM-IV-R criteria.
Participants must meet the criteria for a current major depressive episode AND have
had at least two episodes (i.e., it is recurrent depression) OR the current episode lasted
2 years ormore (long-termMDDor dysthymiawere accepted). Participants had to be able
to give informed consent. Participants must have tried at least one-first-line treatment and
not responded.
Exclusion criteria – those under 18, those unable to give informed consent, those with
current suicidal intent or behaviour, psychosis, bipolar disorder, PTSD, dementia, brain
injury, current drug/alcohol dependence, epilepsy, pregnancy, current opiate analgesic
use, ECT in the last 6 months, primary mental health diagnosis was not long-term
depression.
Measures
The primary outcome measure for the study was the HRSD (Hamilton, 1960). This was
collected at entry to the study and after the intervention and at 3-month follow-up by the
first author who was trained to use all measures. Also collected at the start, end, and
follow-up were the Impact of Event Scale – revised (IES-r; Creamer, Bell, & Failla, 2003),
the Patient Health Questionnaire – 9 items (PHQ-9; Kroenke, Spitzer, & Williams, 2001)
and the Beck Depression Inventory (v.2) (BDI-II; Beck, Steer, & Brown, 1996). At the start
of every session, the clients completed the PHQ-9.
Hamilton Rating Scale for Depression
TheHRSD is a 24-item clinician-rated scale for depression symptoms. It has been shown to
have good reliability between raters (Hamilton, 1960) and is sensitive to change over time
and treatment (Miller, Bishop, Norman, & Maddever, 1985). This is the primary outcome
for the indicators of symptoms change. Scores range from 0 to 75 and 8 or less = no
symptoms, 9 to 18 = mild, 19 to 26 = moderate, 27 to 34 = severe, 35+ (max score
75) = very severe.
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Hamilton Rating Scale for Depression was the primary outcome measure as this is a
validated and recognized scale worldwide. It has been the gold standard in depression
rating scales for 40 years (Bagby, Ryder, Schuller, & Marshall, 2004). It enables the
research to be compared to other research. The HRSD is heavily biological in its design
whereas the BDI is more responsive to the cognitive aspects of depression. It is advisable
to have more than one scale covering differing perspectives and symptom domains (Roth
& Fonagy, 2005). The HRSD and the BDI-II are considered two of the best tested and
reliable rating scales available for depression (Cusin, Yang, Yeung, & Fava, 2009) but are
not commonly used in clinical practice in theUnitedKingdom. TheBDI-II is regularly used
in American studies but less so in the United Kingdom. The PHQ-9 is a standard measure
used in IAPT in the United Kingdom so allows the results to be comparable to the IAPT
data set should that be appropriate.
The Patient Health Questionnaire – 9 items
The PHQ-9 (Kroenke & Spitzer, 2002) is a self-rated depression measure routinely used in
IAPT services that takes about two minutes to complete, and it is validated in a UK
population (Gilbody, Richards, & Barkham, 2007). The IAPT handbook recommends the
following interpretation of PHQ-9 scores, 1–4 minimal depression, 5–9 mild depression,
10–14 moderate depression, 15–19 moderately severe depression, and 20–27 severe
depression (Department of Health, 2011).
Beck Depression Inventory (v.2)
The BDI-II is a 21-item self-report rating scale for depression (Beck et al., 1996), it covers
all nine of the DSM diagnostic criteria rather than the six of the BDI, and it includes
increases aswell as decreases in somatic symptoms (Dozois, Dobson,&Ahnberg, 1998). It
is used in many research studies into depression and is the primary depression tool in the
United States (Sharp & Lipsky, 2002). It has good validity when compared with other self-
rate scales and clinician-ratedmeasures for depression (Steer, Ball, Raneeri, &Beck, 1997).
The interpretation of the score should 1–10no depression, 11–16mildmood disturbance,
17–20 borderline clinical depression, 21–30 moderate depression, 31–40 severe
depression, and over 40 extreme depression (Beck et al., 1996).
Impact of Event Scale – revised
The IES-r is a self-report scale measuring traumatic stress; it was developed to improve the
IES scale, which did not include persistent hyper-arousal (Creamer et al., 2003). It is a
useful instrument for measuring traumatic stress, and a score of 33 or more gives optimal
diagnostic accuracy for PTSD (Creamer et al., 2003).
To assess whether participants had made clinically significant and statistically
significant changes, the reliable change index (RCI) was used. Reliable change is a way
of determining whether the change you see is likely to be real or simply an artefact due to
the unreliability of the instrument (Jacobson& Truax, 1991). A RCI can be determined for
each measure. If the client’s score on the measure changes between the initial and end of
therapy reading by more than the RCI, then we can be confident that in 95% of cases this
change will be real and not due to error in the measure (i.e., it is statistically reliable). The
RCI was calculated for all of the scales. Due to the small sample size in this study,
previously publishedmeans, standard deviations, and internal consistency scores derived
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from larger samples were used to calculate the RCIs as they may be considered more
reliable.
Although it is important to know that change is reliable, it must be meaningful to the
clinicians as well and therefore needs to be related to caseness and severity of illness. The
RCI tells us whether the change is statistically reliable, and it does not necessarily tell us
whether it is clinically meaningful (Barkham & Mellor-Clark, 2003). Many articles
reporting a clinicalmeasurewill assign a cut-off level (Table 1) to determinewhat levels of
symptoms are clinically significant enough to be considered a ‘case’. Sometimes they also
suggest levels of change that can be considered clinically significant or an adequate
response to treatment. This acknowledges that although a client’s symptoms may not
disappear entirely this does notmean that a treatment has notmade amajor improvement
to their life.
The repeated measure
Using this repeated measure, it was possible to track fluctuations in mood in between the
sessions; this aims to add insight into the before and after measures and enabled the
research to be placed in context of the natural changes in depressive symptoms over time
(Turpin, 2001). As has been used in other time series evaluations, the repeated measure
was based on the DSM-IV-R criteria for the disorder of interest (Kellett, 2007), in this case
MDD. The questionswere derived from thewording of the PHQ-9 (Kroenke et al., 2001),
and reflected the essential criteria from both the DSM-IV-R criteria for MDD (APA, 2003)
and the essential criteria forMDD from the ICD-10 (WHO, 1993; question 3). Itwaspiloted
and thewordingwas borrowed from thePHQ-9whichhas been validated for British adults
with depression (Gilbody et al., 2007). The participants were given a paper copy of the
scale to complete every day. Three questions addressed low mood/depression, loss of
interest or pleasure in activities, and energy levels. The questions were set out in the
standard visual analogue form, and the participant had to make a mark on the line
representing their mood at that time. The scales had anchored endpoints, for instance ‘I
Table 1. Reliable change and clinically significant response
Measure Caseness cut-off
Clinically significant
response
Reliable
change
Hamilton Rating Scale for
Depression (Hamilton,
1960; Schramm et al., 2011)
<8 is non-clinical At least 50% reduction
in score and score is
now <15
5.95
Patient Health Questionnaire
– 9 items (Kroenke et al.,
2001; Smarr and Keefer,
2011)
<10 is non-clinical At least a 5-point
reduction
6.33
BDI-II = Beck Depression
Inventory (v.2) (Smarr and
Keefer, 2011)
Noofficial level of caseness
but some have suggested
at least 16 points is
required for diagnosis
5-point
decrease = minimal
improvement
10–19 = moderate
20+ = large
8.94
Impact of Event Scale –
revised (Creamer et al.,
2003)
33 ormore indicates PTSD 17.84
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am extremely low or depressed’ to ‘I don’t have low mood’ (see Appendix). Completed
forms were returned to the therapy session where participants collected the next week’s
diary. Afterwards, the mark was measured from the right-hand side to give a decreasing
number as the symptoms improved.
At the end of the treatment, all participants were asked the NHS ‘Friends and Family’
question, would you recommend this treatment to friends or family in the same situation?
The intervention
The EMDR adhered to the manualized eight-phase standard protocol design by
Francine Shapiro and approved by the EMDRIA institute (Shapiro, 2001). There are
numerous different protocols for EMDR for a range of illnesses, conditions, and
situations, but only the original standard protocol has been used in clinical trials. For
this reason, the standard protocol was chosen for this study. To ensure the therapists
adhered to the standard protocol, they were asked to complete a therapy process
record each session. Therapy was twice a week in 60-min sessions in a National
Health Service building that provided psychological therapies. Participants could
receive up to 20 sessions, but the final number was a clinical decision. Three
therapists provided EMDR; they were all fully qualified to do so and had been trained
by EMDRIA institute approved trainers to at least level three.
The eight phases of EMDR are (1) Client history and treatment planning, (2)
Preparation, (3) Assessment (of the trauma), (4) Desensitization, (5) Installation, (6)
Body Scan, (7) Closure, and (8) Re-evaluation (Shapiro, 2001). It is phase four where
the bilateral stimulation, that is the key (and controversial) component of EMDR,
begins. Some early EMDR researchers only counted the number of sessions from the
moment bilateral stimulation began. This study counts the number of sessions from
the moment of first contact with the therapist. However, there is no set time period
for the length of time each of these phases should take. Depending on the client, it
may be necessary to spend several sessions planning and preparing, others may get
through to phase four or five in one session. This is entirely a clinical decision and is
based on the needs of the client.
Analysis
For the before and after standardized measures, reliable change indices (Jacobson &
Truax, 1991) and clinically significant change (Barkham & Mellor-Clark, 2003) were
calculated. For the primary measure, the HRSD, clinically significant change can be
defined as the participant scoring below eight (for remission) or having a 50% drop in
score and now scored under 15 (for response; Hamilton, 1960). MS Excel and SPSS were
used for the analysis.
Ethical standards
The authors assert that all procedures contributing to this work comply with the ethical
standards of the relevant national and institutional committees on human experimenta-
tion and with the Helsinki Declaration of 1975, as revised in 2008. The research was
approved by the Research Ethics Committee on behalf of the UKNational Research Ethics
Services.
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Results
Participants
Fifteen peoplewere screened; twowere excluded as they had PTSD.Of the 13who signed
consent forms, three did not begin treatment.Onewasno longer depressed sowas instead
referred to relapse prevention work, one repeatedly turned down appointments and
finally stopped responding to contacts and one could not start EMDR as a therapist could
not be found for him. Ten people began treatment, and two dropped out. One dropped
out after two sessions reporting family issues and not being able to commit to the
treatment. One was referred to the community mental health team. This left eight people
who fully engaged with the treatment programme (Figure 1).
The participants ranged in age from 29 to 65 years old with a mean age of 46 (standard
deviation 13.1); eight of the 13were women. The reported first onset of depression ranged
from9 to43 years, and the self-reported lengthof the current episode ranged from1 month
15 people 
screened
2 have PTSD and are excluded –
care from IAPT
10 people 
start therapy
13 people 
consented
1 recovers – no longer meets DSM-IV criteria 
for depression (referred to mindfulness 
relapse prevention group)
1 opt out (no response to letters)
1 meeting criteria but no therapist available in 
the time frame (offered EMDR outside the 
research clinic)
1 withdraws after 2 sessions due to home 
commitments – referred back to IAPT
1 discharged after 9 sessions – unsuitable for 
further treatment – referred to community 
mental health team (CMHT)
8 people 
fully engage
1 deteriorates and has to be discharged after 8 
sessions - referred to CMHT 
7 people complete treatment – all 
are classed as responders to 
treatment
Figure 1. Flow chart of participant recruitment and retention.
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to 10 years. All had received at least one talking therapy and at least one antidepressant
medication in the past. The range of talking therapies were CBT, computerized CBT,
cognitive analytic therapy, counselling, bereavement counselling, workplace well-being,
psychodynamic therapy, hypnotherapy, andpain-teampsychology.All hadMDDconfirmed
by structured clinical interview, most reported recurrent depression (11/13), just over half
had chronic depression (7/13), and some had both (5/13).
Of the 13 participants recruited, three received no treatment sessions. As this is a
feasibility study, an intention-to-treat analysis was not conducted and their pre-therapy
data were excluded. Only one other participant did not provide after therapy outcome
data, participant 008. He did begin therapy but he was discharged after eight sessions, as
the therapist deemedhimunsuitable for treatment at the present time. After his discharge,
he did not respond to our requests to meet for end measures. This was then treated as a
dropout. As this is a failure of treatment, his scores are included in the analyses.
Participants who received treatment had between eight and twenty sessions (average
17.6 SD 3.8). Phases 2, 3, and 4 of the standard protocolwere themost frequently recorded.
Phase two is resourcing where the psychological resources and coping strategies of the
participant are assessed and strengthened (present in 9–19 sessions). Phase three is the
assessment phase where the target memory is assessed (present in 5–17 sessions). Phase
four isdesensitization and iswhen thebilateral stimulation isused todesensitize the client to
the traumatic memory (present in 1–16 sessions). All participants preferred tapping to eye
movements, so the majority of bilateral stimulation sessions used this method.
Clinical measures
The mean change score on the HRSD was a decrease of 14.1 (SD 4.8). Table 2 shows the
detail of the changes for each participant.
Table 2. The change in Hamilton Rating Scale for Depression (HRSD), if that change was reliable and
clinically significant and if any change in symptoms was maintained at follow-up
Participant
HRSD
Pre
HRSD
Post Change Reliable?a Clinically sig?a HRSD F/U
Are
benefits
maintained?
1 17 3 14 Yes Yes – remission 4 Yes
3 13 5 8 Yes Yes – remission 6 Yes
4 25 9 16 Yes Yes – response 7 Yes
5 26 3 23 Yes Yes – remission 7 Yes
6 13 25 12 Yes Yes but
deteriorated
5 Improved
7 21 5 16 Yes Yes – remission 4 Yes
8 22 – Dropout –
10 23 11 12 Yes Yes – response –
11 10 2 8 Yes Yes – remission 5 Yes
12 26 8 18 Yes Yes – response –
Mean
(SD)
19.6
(5.9)
7.9
(7.1)
14.1
(4.8)
5.4
(1.3)
Note. aA 6-point change is required for change to be considered reliable on the HRSD, for change to be
clinically significant the participants post-score must be below 8 or have dropped by at least 50% and now
be below 15.
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Figure 2 is a Jacobson plot (Jacobson & Truax, 1991) of the before and after scores for
the HRSD, which shows if any change is reliable, as measured on the RCI, and if it is
clinically significant. Any point below the diagonal ‘no change’ line is a participant who
improved during the course of therapy. If that point is outside the tramlines (dashed), then
the change is statistically reliable, and if it is below the horizontal line, then the participant
is now in remission. On the HRSD, change can be clinically significant but not reach the
point of remission; that is, the participant has shown a major improvement in his or her
symptoms, but they are not yetwell enough to be considered in remission; Table 2 shows
this in more detail.
The table and Jacobson plot show that of the nine people with before and after
measures, only one deteriorated and all the othersmeet the criteria for response. Of these,
five are in remission (001, 003, 005, 007, and 011) and three responded to treatment with
at least a 50% reduction in HRSD score and are now rated as having mild depression (004,
010, and 012). The person who deteriorated (006) went from mild-to-moderate
depression with an almost 50% increase in his HRSD score. Two people dropped out
and did not receive a full treatment of EMDR but did provide pre-/post-data; their scores
correspond to the points at coordinates 13, 25 and 23, 11.
The secondary measures also showed clinically significant improvement as Table 3
summarizes. Table 3 also shows how the results seen on the clinician-rated HRSD are
remarkably consistent with the client rated BDI-II and PHQ-9. On the three depression
measures, HRSD, BDI-II, and PHQ-9, there is agreement on almost all cases. Participant 10
did not improve as much on the self-report scales as she did on the clinician-rated score
and participant 11 did not improve as much on the PHQ-9 as she did on the other two
measures.
The IES-r clinically significant changes need to be read with care. The change is only
clinically significant if the participantmoves across a specified cut-off point, but not all the
participants started on the pathological side of the cut-off (i.e., they did not have evidence
of being traumatized or had normal social functioning). These participants cannot achieve
clinically significant change no matter how much they improve. Change in participant 6
was clinically significant and statistically reliable but he deteriorated.
Figure 2. Jacobson plot for the Hamilton Rating Scale for Depression (HRSD).
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The daily measure
Thedailymeasure showed somuchvariability across all participants for all threequestions
that the results are difficult to interpret. However, there was no evidence of spontaneous
improvement during the baseline across participants. An example is shown in Figure 3.
Friends and family question
Every participant who responded to the friends and family question reported that, yes,
they would recommend EMDR as a treatment for depression to friends and family in the
same situation. In fact, two of them did approach the researcher to see if they could get
friends into the research clinic. The respondents included the participant whose
depression got worse, but he still said he would recommend it and would accept it again
himself if offered in the future.
Discussion
Of the nine people who fully engaged with the treatment programme, eight had a
clinically significant and statistically reliable positive response. Five people scored as
subclinical for depression at the end of treatment. All participants would recommend it to
friends and family. This indicates that (1) EMDRcan be delivered to this patient groupwith
no observed difficulties in this small sample, (2) the treatment was acceptable, and (3) the
treatment was associated with reduction in the symptoms of depression. Although due to
the lack of an active control group and the very small sample size here, the magnitude of
the effect or its reliability in a larger sample cannot be known.
One person’s depression worsened during treatment. When asked about this, the
participant did not feel the EMDR had been a cause of the deterioration, and he reported
that hewould like to try it again in the future. Treatment safety should be taken as seriously
in psychotherapy as it is in pharmacology (Parry, Crawford, & Duggan, 2016). Based on
Parry et al. (2016) suggested terminology, this participant saw a clinically significant
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deterioration in his mental state, but with no evidence of harm. The EMDR therapists
involved suggested that there needs to be a careful assessment of the psychological
resources and coping methods available to the client before starting bilateral stimulation.
They found this part of the protocol took longer in the clients within the study thanwould
be expected when working with clients with PTSD.
Many EMDR proponents claim it can be used for far more than just PTSD (Shapiro,
1995, 2005). This clinical case series complements clinical reports of the success of EMDR
to treat depression (Bae, Kim,&Park, 2008;Grey, 2011), but the literature still lacks a large
randomized controlled trial to provide confirmation of efficacy and effect size (Wood &
Ricketts, 2013).
Participants with PTSD, as assessed by the structured clinical interview, were
excluded from the study. Despite this, the IES-r results show that those who were
classified as traumatized before the treatment were no longer traumatized at the end and
this remained true at follow-up. Despite screening negative for PTSD, many of the
participants (7/13) scored highly for trauma on the IES-r. Thismay highlight the difference
between PTSD criterion A events (sometimes referred to as ‘big T trauma’ in the EMDR
literature) and negative life events (‘small t trauma’). Negative life events may not be life-
threatening, but they can still have a profoundly damaging effect on a person’s mental
state (Shapero et al., 2014; Shapiro, 2001). The AIPmodel states that thememory of these
events can fail to be fully processed regardless of whether or not the event is life-
threatening (Solomon&Shapiro, 2008). It also predicts that it is thesememories that cause
negative thinking styles and that by processing the memory, the negative thinking style
can be altered.
This study adds to a small, but growing body of literature that indicates EMDR has
potential to treat depression (Bae et al., 2008; Grey, 2011; Hofmann et al., 2014) and
symptoms of depression and hypomania in bipolar patients (Novo et al., 2014). It also
shows that EMDRdoes not necessarily need to be an adjunct to another therapy but can be
used as the standard protocol describes (Shapiro, 2001). The Hofmann study used EMDR
sessions (between 3 and 16) as an adjunct to CBT (around 38 sessions), with the
CBT+EMDR group achieving significantly greater improvements in depression symptoms
than those receiving CBT alone. By using only standard protocol EMDR, this study appears
to have seen results equivalent to the German study but in half the number of sessions (20
instead of 40–50 sessions; Hofmann et al., 2014).
Limitations
This is a feasibility study involving a case serieswithout a control group and therefore does
not aim to establish efficacy. As all the participants received EMDR, the evaluators were
not blind to treatment. The use of a predictive baseline and continuous measurement
sought to partially control for the passage of time. The length of the baseline period was
determined by how quickly a therapist became available and was not randomized. This
means it is not a true experimental design, but it was considered clinically more
appropriate.
Recommendations for research
This small feasibility study has shown that it is feasible to use EMDR to treat long-term
depression. There is therefore a case for further research to investigate its efficacy,
compare it to CBT and mechanism of action. Work will also be needed to see whether
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EMDRneeds to be targeted at service userswith depression that clearly links to a traumatic
past or if it can be used with anyone with depression. As long-term depression is a
relapsing/remitting condition, a significant follow-up period (preferably at least
12 months) is required to ensure improvements are maintained.
Conclusions
This study reports clinically significant and statistically reliable improvement in eight of
nine participants who received a complete treatment of EMDR, with one client
withdrawing from therapy. One participant dropped out. As no single talking therapy
or treatment has ever proved to be all things to all people, numerous psychotherapies
should be researched to provide a wider range of treatment options for these prevalent
and disabling disorders. EMDR has the potential to be a treatment for long-term
depression.
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Appendix: Table A1. An example of 1 day of the repeated questions
Date
Low mood/depression ‘I am extremely low or
depressed’
__________________ ‘I don’t have low mood’
Interest or
pleasure in activities
‘I have no interest in
doing things’
__________________ ‘I get involved’
Energy levels ‘I have no energy’ __________________ ‘I have enough energy’
16 Emily Wood et al.
